FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

330349004: Neomycin sulfate 0.5% single-use eye drops (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    467870014 Neomycin sulphate 0.5% single-use eye drops en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    467871013 Neomycin sulfate 0.5% single-use eye drops en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1192105011 Neomycin sulfate 0.5% single-use eye drops (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3546221000005111 neomycinsulfat 0,5 % øjendråber til engangsbrug da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    neomycinsulfat 0,5 % øjendråber til engangsbrug Is a neomycin til topikal anvendelse false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug Is a antibiotikum til oftalmisk anvendelse false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. neomycin til topikal anvendelse false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin sulfate false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antiinfektiøst middel til huden false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug Is a Product containing neomycin in ophthalmic dosage form false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug Is a Neomycin sulfate 5 mg/mL eye drops false Inferred relationship Some
    neomycinsulfat 0,5 % øjendråber til engangsbrug Has manufactured dose form Eye drops false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    GB English

    US English

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start